Neural stem cell-derived exosomes and regeneration: cell-free therapeutic strategies for traumatic brain injury.


Journal

Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581

Informations de publication

Date de publication:
08 08 2023
Historique:
received: 18 01 2023
accepted: 06 07 2023
medline: 10 8 2023
pubmed: 9 8 2023
entrez: 8 8 2023
Statut: epublish

Résumé

Regenerative repair of the brain after traumatic brain injury (TBI) remains an extensive clinical challenge, inspiring intensified interest in therapeutic approaches to explore superior repair strategies. Exosome therapy is another research hotspot following stem cell alternative therapy. Prior research verified that exosomes produced by neural stem cells can participate in the physiological and pathological changes associated with TBI and have potential neuroregulatory and repair functions. In comparison with their parental stem cells, exosomes have superior stability and immune tolerance and lower tumorigenic risk. In addition, they can readily penetrate the blood‒brain barrier, which makes their treatment efficiency superior to that of transplanted stem cells. Exosomes secreted by neural stem cells present a promising strategy for the development of novel regenerative therapies. Their tissue regeneration and immunomodulatory potential have made them encouraging candidates for TBI repair. The present review addresses the challenges, applications and potential mechanisms of neural stem cell exosomes in regenerating damaged brains.

Identifiants

pubmed: 37553595
doi: 10.1186/s13287-023-03409-1
pii: 10.1186/s13287-023-03409-1
pmc: PMC10408078
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

198

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

J Control Release. 2019 Aug 28;308:119-129
pubmed: 31325471
Chem Rev. 2018 Feb 28;118(4):1917-1950
pubmed: 29384376
Blood. 2012 Jan 19;119(3):756-66
pubmed: 22031862
Neuroreport. 2020 Aug 5;31(11):798-805
pubmed: 32590394
Neuroscience. 2019 May 1;405:148-157
pubmed: 29660443
Front Bioeng Biotechnol. 2022 Jan 05;9:811971
pubmed: 35071216
J Circ Biomark. 2016 Apr 1;5:7
pubmed: 28936255
Cold Spring Harb Perspect Biol. 2013 Sep 01;5(9):
pubmed: 24003212
Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):16086-16094
pubmed: 31320591
Cell Transplant. 2019 Jun;28(6):662-670
pubmed: 30520322
Curr Biol. 2018 Apr 23;28(8):R435-R444
pubmed: 29689228
Semin Cell Dev Biol. 2015 Apr;40:82-8
pubmed: 25765629
Sci Rep. 2016 Mar 24;6:23550
pubmed: 27009329
Acta Pharmacol Sin. 2018 Apr;39(4):501-513
pubmed: 29219950
Lancet. 2002 Jul 27;360(9329):295-305
pubmed: 12147373
Blood. 1989 Oct;74(5):1844-51
pubmed: 2790208
Mol Cancer. 2020 Mar 25;19(1):66
pubmed: 32213181
Int J Cancer. 2005 Apr 20;114(4):613-22
pubmed: 15609328
Brain Res. 2020 Feb 15;1729:146615
pubmed: 31863730
Cell Mol Life Sci. 2019 Mar;76(6):1093-1106
pubmed: 30569278
Development. 2019 Feb 18;146(4):
pubmed: 30777863
Neurotherapeutics. 2020 Apr;17(2):446-456
pubmed: 32056100
J Biol Chem. 1984 Aug 10;259(15):9776-82
pubmed: 6146620
PLoS One. 2016 Jan 11;11(1):e0146353
pubmed: 26752061
Elife. 2023 Apr 27;12:
pubmed: 37104115
Neural Regen Res. 2023 Feb;18(2):404-409
pubmed: 35900437
J Control Release. 2015 Jun 10;207:18-30
pubmed: 25836593
Cell Commun Signal. 2019 Aug 16;17(1):96
pubmed: 31419975
Mol Cell. 2014 Oct 23;56(2):193-204
pubmed: 25242146
Front Neurol. 2019 Jan 17;9:1097
pubmed: 30719019
Circ Res. 2017 May 12;120(10):1658-1673
pubmed: 28495996
Nucleic Acids Res. 2012 Jan;40(Database issue):D1241-4
pubmed: 21989406
J Biol Chem. 2022 Apr;298(4):101828
pubmed: 35305988
Life Sci. 2020 Aug 1;254:117772
pubmed: 32437794
Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):455-468
pubmed: 31047959
Neurochem Res. 2021 Oct;46(10):2538-2550
pubmed: 33961207
J Neurosci. 2013 Mar 6;33(10):4216-33
pubmed: 23467340
Stem Cell Res Ther. 2018 Jun 13;9(1):154
pubmed: 29895321
Int J Physiol Pathophysiol Pharmacol. 2017 Dec 25;9(6):188-191
pubmed: 29348795
Eur J Neurosci. 2021 Feb;53(3):706-719
pubmed: 32939863
Prog Neurobiol. 2019 Feb;173:1-17
pubmed: 29758244
Nat Commun. 2018 Apr 3;9(1):1305
pubmed: 29610454
Nat Chem Biol. 2017 Sep;13(9):951-955
pubmed: 28671681
Stem Cell Rev Rep. 2023 May;19(4):1001-1018
pubmed: 36652144
Nature. 2017 Aug 3;548(7665):52-57
pubmed: 28746310
Vet Res Commun. 2014 Dec;38(4):297-305
pubmed: 25178417
Nat Cell Biol. 2012 Jun 29;14(7):654-5
pubmed: 22743708
Mech Dev. 2015 Nov;138 Pt 1:56-62
pubmed: 26103548
J Neurotrauma. 2021 Oct 1;38(19):2731-2746
pubmed: 34130484
J Extracell Vesicles. 2020 Aug 26;9(1):1809064
pubmed: 32944193
Neuropathology. 2020 Apr;40(2):121-137
pubmed: 32037635
EBioMedicine. 2018 Dec;38:273-282
pubmed: 30472088
Nat Biotechnol. 2011 Apr;29(4):341-5
pubmed: 21423189
Theranostics. 2021 Jan 1;11(7):3183-3195
pubmed: 33537081
Stroke. 2011 Aug;42(8):2342-50
pubmed: 21737804
Neural Regen Res. 2020 Jun;15(6):1023-1024
pubmed: 31823874
Biomed Res Int. 2014;2014:756327
pubmed: 24860829
Front Immunol. 2021 Jun 23;12:705920
pubmed: 34249016
Neural Regen Res. 2017 Jan;12(1):19-22
pubmed: 28250732
Front Mol Neurosci. 2019 Oct 04;12:240
pubmed: 31636538
Nat Rev Neurosci. 2006 Jan;7(1):41-53
pubmed: 16371949
Science. 2020 Feb 7;367(6478):
pubmed: 32029601
ACS Nano. 2022 Jul 26;16(7):10811-10823
pubmed: 35786851
Leukemia. 2016 Nov;30(11):2221-2231
pubmed: 27150009
Biochimie. 2007 Feb;89(2):205-12
pubmed: 17157973
PLoS One. 2014 Apr 16;9(4):e95272
pubmed: 24739954
J Neurotrauma. 2000 Oct;17(10):927-38
pubmed: 11063058
Front Cell Dev Biol. 2021 May 13;9:601600
pubmed: 34055767
Nature. 2010 Apr 8;464(7290):864-9
pubmed: 20305637
EMBO Rep. 2011 Jun 03;12(8):811-7
pubmed: 21637297
J Neurotrauma. 2020 Jun 1;37(11):1358-1369
pubmed: 31774030
Front Hum Neurosci. 2014 Jun 27;8:382
pubmed: 25018718
Theranostics. 2021 Aug 18;11(18):8926-8944
pubmed: 34522219
J Med Chem. 2013 Sep 26;56(18):7302-11
pubmed: 23964991
Exp Neurol. 2003 Jun;181(2):115-29
pubmed: 12781986
Rev Neurosci. 2020 Jan 28;31(2):143-159
pubmed: 31539363
Neurosci Lett. 2022 May 14;779:136635
pubmed: 35436510
J Adv Res. 2020 May 25;24:435-445
pubmed: 32551140
Int J Nanomedicine. 2014 Oct 21;9:4893-7
pubmed: 25364247
J Control Release. 2020 Oct 10;326:599-614
pubmed: 32730952
Oxid Med Cell Longev. 2019 Nov 13;2019:3753485
pubmed: 31814872
Nat Rev Nephrol. 2018 Aug;14(8):493-507
pubmed: 29895977
Autophagy. 2007 Nov-Dec;3(6):586-90
pubmed: 17786021
Free Radic Biol Med. 2022 Nov 1;192:25-36
pubmed: 36096356
FEBS Lett. 2015 May 8;589(11):1257-65
pubmed: 25862500
Cell Rep. 2018 Apr 3;23(1):78-89
pubmed: 29617675
Science. 2004 May 28;304(5675):1338-40
pubmed: 15060285
Viruses. 2020 Oct 01;12(10):
pubmed: 33019624
Colloids Surf B Biointerfaces. 2011 Oct 1;87(1):146-50
pubmed: 21640565
Stem Cells Transl Med. 2023 Mar 17;12(3):140-153
pubmed: 36847078
J Nanobiotechnology. 2021 Dec 30;19(1):459
pubmed: 34965878
Drug Deliv. 2020 Dec;27(1):585-598
pubmed: 32264719
J Neurosci Methods. 2016 Oct 15;272:38-49
pubmed: 27382003
J Clin Invest. 2016 Apr 1;126(4):1190-7
pubmed: 27035810
Cells. 2020 Jul 17;9(7):
pubmed: 32709045
Theranostics. 2021 Jan 1;11(3):1046-1058
pubmed: 33391520
Neurosurgery. 2000 Sep;47(3):546-61
pubmed: 10981741
J Clin Invest. 2016 Apr 1;126(4):1152-62
pubmed: 27035807
Annu Rev Pharmacol Toxicol. 2015;55:439-464
pubmed: 25292428
Int J Mol Sci. 2021 Mar 04;22(5):
pubmed: 33806480
Cell Mol Biol Lett. 2022 Oct 3;27(1):83
pubmed: 36192691
Cell Mol Neurobiol. 2016 Apr;36(3):301-12
pubmed: 27053351
Front Bioeng Biotechnol. 2020 Sep 10;8:997
pubmed: 33015001
Nat Rev Neurol. 2019 Apr;15(4):193-203
pubmed: 30700824
Cell Biochem Funct. 2020 Jun;38(4):373-383
pubmed: 31885106
Biomed Res Int. 2022 Aug 12;2022:6409346
pubmed: 35993050
Cells. 2021 Aug 01;10(8):
pubmed: 34440728
Annu Rev Cell Dev Biol. 2014;30:255-89
pubmed: 25288114
J Control Release. 2014 Oct 28;192:262-70
pubmed: 25084218
Theranostics. 2017 Jan 26;7(3):789-804
pubmed: 28255367
Adv Healthc Mater. 2022 Mar;11(5):e2100047
pubmed: 33951319
Biomater Sci. 2022 Mar 29;10(7):1803-1811
pubmed: 35234220
Biomedicines. 2021 Jun 10;9(6):
pubmed: 34200905
Small GTPases. 2018 Mar 4;9(1-2):95-106
pubmed: 28135905
Proteomics. 2008 Oct;8(19):4083-99
pubmed: 18780348
Adv Drug Deliv Rev. 2013 Mar;65(3):391-7
pubmed: 22921840
Front Cell Dev Biol. 2022 Jul 06;10:900418
pubmed: 35874827
Biomaterials. 2018 Jan;150:137-149
pubmed: 29040874
J Neurosci. 2021 Feb 17;41(7):1597-1616
pubmed: 33452227

Auteurs

Lin Zhong (L)

Department of Hematology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, Sichuan, China.

Jingjing Wang (J)

Tianjin Key Laboratory of Neurotrauma Repair, Institute of Neurotrauma Repair, Characteristic Medical Center of People's Armed Police Forces, Tianjin, 300162, China.

Peng Wang (P)

Department of Health Management, Tianjin Hospital, Tianjin, 300211, China.

Xiaoyin Liu (X)

Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, Sichuan, China.

Peng Liu (P)

Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, Sichuan, China.

Xu Cheng (X)

Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610064, Sichuan, China.

Lujia Cao (L)

Department of Hematology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, Sichuan, China.

Hongwei Wu (H)

Department of Hematology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, Sichuan, China. 2327646115@qq.com.

Jing Chen (J)

Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, Sichuan, China. chenjing6811@126.com.

Liangxue Zhou (L)

Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, Sichuan, China. zhlxlll@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH